FDA Clears Enteral Suspension (Duopa) for Parkinson's FDA Clears Enteral Suspension (Duopa) for Parkinson's

Duopa (AbbVie) enteral suspension is given via a portable infusion pump that delivers carbidopa and levodopa into the small intestine for 16 hours to reduce motor fluctuations. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news